Massachusetts Top Companies List by Market Cap as of January 2024

Massachusetts Top Companies List by Market Cap as on Jan-05-2024. Biggest Massachusetts Companies List by Market Cap in January 2024. Massachusetts Largest Companies in January 2024.

Massachusetts Top Companies by Market Cap in 2024
Massachusetts Top Companies by Market Cap in 2024, Massachusetts Largest Companies in 2024, Biggest Massachusetts Companies by Market Cap.

  1. Mersana Therapeutics

    World Rank (Jan-05-2024)
    16,205
    Market Cap (Jan-05-2024)
    0.279 Billion USD
    World Rank (Jul-30-2023)
    19,774
    Market Cap (Jul-30-2023)
    0.144 Billion USD
    World Rank (Dec-25-2022)
    11,492
    Market Cap (Dec-25-2022)
    0.578 Billion USD
    World Rank (Jan-07-2022)
    14,071
    Market Cap (Jan-07-2022)
    0.45 Billion USD
    Annual Revenue in USD
    1 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Mersana Therapeutics is a Biopharmaceutical company specializing in the discovery and development of antibody drug conjugate (ADC) therapies to treat patients fighting cancer. The company total assets is 107.5 million USD as on 2019, total liabilities is 29.2 million USD as on 2019, annual revenue is 42.1 million USD as on 2019 and total equity is 78.3  million USD as on 2019.The headquarters is in USA.
    Company Website
    MERSANA THERAPEUTICS

  2. Franklin Street Properties

    World Rank (Jan-05-2024)
    16,309
    Market Cap (Jan-05-2024)
    0.273 Billion USD
    World Rank (Jul-30-2023)
    18,914
    Market Cap (Jul-30-2023)
    0.170 Billion USD
    World Rank (Dec-25-2022)
    16,066
    Market Cap (Dec-25-2022)
    0.284 Billion USD
    World Rank (Jan-07-2022)
    11,874
    Market Cap (Jan-07-2022)
    0.65 Billion USD
    Annual Revenue in USD
    209 Million USD
    Annual Net Income in USD
    92 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    USA
    Yahoo @ Frankfurt
    Company Profile
    Franklin Street Properties is a Real Estate Investment Trust company. The company annual revenue is 88.9 million USD. The headquarters is in USA.
    Company Website
    FRANKLIN STREET PROPERTIES

  3. Pimco Strategic Income Fund

    World Rank (Jan-05-2024)
    16,313
    Market Cap (Jan-05-2024)
    0.272 Billion USD
    World Rank (Jul-30-2023)
    16,906
    Market Cap (Jul-30-2023)
    0.248 Billion USD
    World Rank (Dec-25-2022)
    17,271
    Market Cap (Dec-25-2022)
    0.230 Billion USD
    World Rank (Jan-07-2022)
    16,661
    Market Cap (Jan-07-2022)
    0.30 Billion USD
    Annual Revenue in USD
    -20 Million USD
    Annual Net Income in USD
    -20 Million USD
    Annual Results for Period Ending
    Jun-2020 ending year
    Headquarters Country
    USA
    Yahoo @ NYSE

  4. J.Jill Inc.

    World Rank (Jan-05-2024)
    16,346
    Market Cap (Jan-05-2024)
    0.270 Billion USD
    World Rank (Jul-30-2023)
    17,113
    Market Cap (Jul-30-2023)
    0.238 Billion USD
    World Rank (Dec-25-2022)
    17,238
    Market Cap (Dec-25-2022)
    0.232 Billion USD
    World Rank (Jan-07-2022)
    19,082
    Market Cap (Jan-07-2022)
    0.20 Billion USD
    Headquarters Country
    USA
    Company Profile
    J.JILL, INC. is unic and Fashionable Women's clothing, Accessories and Footwear.
    Company Website
    J.JILL, INC.

  5. TScan Therapeutics Inc.

    World Rank (Jan-05-2024)
    16,349
    Market Cap (Jan-05-2024)
    0.270 Billion USD
    World Rank (Jul-30-2023)
    21,700
    Market Cap (Jul-30-2023)
    0.100 Billion USD
    World Rank (Dec-25-2022)
    26,724
    Market Cap (Dec-25-2022)
    0.036 Billion USD
    World Rank (Jan-07-2022)
    22,171
    Market Cap (Jan-07-2022)
    0.11 Billion USD
    Headquarters Country
    USA
    Company Website
    TSCAN THERAPEUTICS, INC.

  6. J. Jill Inc.

    World Rank (Jan-05-2024)
    16,355
    Market Cap (Jan-05-2024)
    0.270 Billion USD
    World Rank (Jul-30-2023)
    15,630
    Market Cap (Jul-30-2023)
    0.312 Billion USD
    Headquarters Country
    USA
    Company Website
    J. Jill Inc.

  7. Inozyme Pharma Inc.

    World Rank (Jan-05-2024)
    16,447
    Market Cap (Jan-05-2024)
    0.265 Billion USD
    World Rank (Jul-30-2023)
    17,663
    Market Cap (Jul-30-2023)
    0.216 Billion USD
    World Rank (Dec-25-2022)
    25,394
    Market Cap (Dec-25-2022)
    0.048 Billion USD
    World Rank (Jan-07-2022)
    20,454
    Market Cap (Jan-07-2022)
    0.15 Billion USD
    Headquarters Country
    USA
    Company Profile
    Inozyme Pharma is a Rare Disease Biopharmaceutical company developing novel therapeutics for the treatment of diseases of abnormal mineralization impacting the vasculature, soft tissue and skeleton. The company estimated annual revenue is currently 7.4 million USD per year. The headquarters is in USA.
    Company Website
    INOZYME PHARMA, INC.

  8. Virtus Total Return Fund

    World Rank (Jan-05-2024)
    16,449
    Market Cap (Jan-05-2024)
    0.265 Billion USD
    World Rank (Jul-30-2023)
    15,992
    Market Cap (Jul-30-2023)
    0.292 Billion USD
    World Rank (Dec-25-2022)
    15,376
    Market Cap (Dec-25-2022)
    0.317 Billion USD
    World Rank (Jan-07-2022)
    14,133
    Market Cap (Jan-07-2022)
    0.45 Billion USD
    Annual Revenue in USD
    35 Million USD
    Annual Net Income in USD
    33 Million USD
    Annual Results for Period Ending
    Nov-2019 ending year
    Headquarters Country
    USA
    Yahoo @ NYSE

  9. Nuveen S&P 500 Dynamic Overwrite Fund

    World Rank (Jan-05-2024)
    16,451
    Market Cap (Jan-05-2024)
    0.265 Billion USD
    World Rank (Jul-30-2023)
    16,139
    Market Cap (Jul-30-2023)
    0.285 Billion USD
    World Rank (Dec-25-2022)
    16,082
    Market Cap (Dec-25-2022)
    0.283 Billion USD
    World Rank (Jan-07-2022)
    16,312
    Market Cap (Jan-07-2022)
    0.32 Billion USD
    Headquarters Country
    USA
    Yahoo @ NYSE

  10. Atea Pharmaceuticals Inc.

    World Rank (Jan-05-2024)
    16,476
    Market Cap (Jan-05-2024)
    0.264 Billion USD
    World Rank (Jul-30-2023)
    16,155
    Market Cap (Jul-30-2023)
    0.284 Billion USD
    World Rank (Dec-25-2022)
    14,183
    Market Cap (Dec-25-2022)
    0.382 Billion USD
    World Rank (Jan-07-2022)
    11,890
    Market Cap (Jan-07-2022)
    0.64 Billion USD
    Annual Revenue in USD
    351 Million USD
    Annual Net Income in USD
    121 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Atea is a Clinical Stage Biopharmaceutical company. It is focused on discovering, developing and commercializing therapies to address the unmet medical needs of patients with life threatening viral diseases. The company annual revenue is 13.6 million USD and 6,904 employees as on 2019. The headquarters is in USA.
    Company Website
    ATEA PHARMACEUTICALS, INC.

Share